However, the abovementioned treatments promoting ovulation may lead to an increased risk of ovarian hyperstimulation syndrome (OHSS) in PCOS patients, in particular, those with high levels of anti-Müllerian hormone (AMH) [23, 30, 32]. Here, AMH is linked to polycystic ovary syndrome.